Status:
UNKNOWN
Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy
Lead Sponsor:
Yanqing Li
Conditions:
Capsule Endoscopy
Cancer of Stomach
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of our study was to demonstrate the efficacy and feasibility of the medical consortium for screening upper gastrointestinal cancers with magnetically controlled capsule gastroscopy.
Detailed Description
In this study, the investigators designed a propective cohort study to evaluate the the efficacy and feasibility of medical consortium for screening upper gastrointestinal cancers (MCSC) with magnetic...
Eligibility Criteria
Inclusion
- asymptomatic subjects undergong magnetically controlled capsule gastroscopy for health checkup in medical consotium;
- subjects able to give informed consent
Exclusion
- suspected or known intestinal stenosis, obstruction, or fistula;
- inoperability of refusal to accept any abdominal surgery;
- dysphagia or gastric paralysis;
- previous history of gastrointestinal disease;
- with pacemaker, implanted-cardiac defibrillator or other implanted electromedical devices;
- need for standard magnetic resonance imaging examination within seven days after swallowing the MCCG, unless the capsule is confirmed to have been excreted;
- other factors that are not suitable for inclusion evaluated by medical stuff
Key Trial Info
Start Date :
December 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04032353
Start Date
December 31 2018
End Date
March 1 2020
Last Update
July 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China, 250012